Sensei Biotherapeutics SNSE
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 31.52 | -131.45 | -170,627 | -170 | ||
| 2025Q4 | 10.67 | 105.15 | -3.74 | -4,957 | -5 | |
| 2025Q3 | 9.45 | 106.33 | -3.62 | -4,851 | -5 | |
| 2025Q2 | 8.58 | 105.68 | -3.91 | -5,206 | -5 | |
| 2025Q1 | 7.88 | 106.17 | -5.45 | -7,274 | -7 | |
| 2024Q4 | 9.8 | 106.72 | -6.17 | -8,274 | -8 | |
| 2024Q3 | 11.96 | 108.17 | -5.77 | -7,823 | -7 | |
| 2024Q2 | 12.4 | 109.4 | -5.6 | -7,787 | -7 | |
| 2024Q1 | 21 | 109.62 | -6.4 | -8,730 | -8 | |
| 2023Q4 | 13.84 | 110.28 | -6 | -8,142 | -7 | |
| 2023Q3 | 16 | 109.11 | -5.6 | -7,737 | -7 | |
| 2023Q2 | 22.8 | 108.87 | -6.2 | -10,177 | -9 | |
| 2023Q1 | 30 | 108.61 | -6.6 | -11,008 | -10 | |
| 2022Q4 | 29.8 | 104.9 | -8 | -13,048 | -12 | |
| 2022Q3 | 31 | 103.99 | -8.6 | -13,941 | -13 | |
| 2022Q2 | 45.4 | 103.37 | -7 | -10,712 | -11 | |
| 2022Q1 | 46.2 | 102.67 | -8 | -12,487 | -12 | |
| 2021Q4 | 116 | 103.9 | -6 | -9,413 | -9 | |
| 2021Q3 | 210.4 | 108.92 | -6.2 | -10,316 | -10 | |
| 2021Q2 | 195.2 | 101.66 | -6 | -9,784 | -10 |